Eton Pharmaceuticals (ETON) Short term Debt (2021 - 2025)

Eton Pharmaceuticals (ETON) has 5 years of Short term Debt data on file, last reported at $8.8 million in Q4 2025.

• For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $8.8 million; the trailing twelve-month figure through Dec 2025 stood at $8.8 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
• Short term Debt advanced to $8.8 million in Q4 2025, from $2.8 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $8.8 million in Q4 2025 to a low of $364000.0 in Q2 2022.
• A 5-year average of $2.6 million and a median of $1.5 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt sank 51.4% in 2022 and jumped 420.81% in 2023, its largest moves.
• Tracing ETON's Short term Debt over 5 years: stood at $1.4 million in 2021, then decreased by 27.15% to $1.0 million in 2022, then jumped by 420.81% to $5.4 million in 2023, then retreated by 23.33% to $4.1 million in 2024, then jumped by 113.07% to $8.8 million in 2025.
• Business Quant data shows ETON's Short term Debt at $8.8 million in Q4 2025, $2.8 million in Q3 2025, and $2.8 million in Q2 2025.